The size limitation affected especially BRCA2 mutation carriers (representing a minority population compared with BRCA1 mutation carriers in the Czech Republic [4]) and BRCA1 mutation carriers with ER-positive BC (representing 22.5% of all BRCA1 mutation carriers in our study). Here, BRCA2 is linked to breast cancer.